Clinical efficacy and MRS analysis of repeated transcranial stimulation in the treatment of spinal cerebellar ataxia type 3

Clinical study of repetitive transcranial magnetic stimulation in patients with spinal cerebellar ataxia

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100044248

Enrollment

Unknown

Registered

2021-03-12

Start date

2021-03-11

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal cerebellar ataxia

Interventions

Really stimulate group:rTMS

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Ataxia symptoms; (2) Family history of genetic testing confirmed SCA3; (3) Sign the informed consent; (4) Aged > 18 years.

Exclusion criteria

Exclusion criteria: (1) Ataxia caused by non-genetic causes; (2) Other neurological diseases; (3) Patients with metal foreign bodies in the skull, brain trauma and brain surgery; (4) Patients with pacemakers, heart stents and cochlear implants; (5) History of epilepsy or abnormal EEG; (6) No cognitive dysfunction; (7) Severe patients with unstable vital signs; (8) Pregnant women, etc.

Design outcomes

Primary

Measure	Time frame
SARA;	—

Countries

China

Contacts

Public ContactLu Xiao-Dong

Affiliated Hospital of Hangzhou Normal University

xdlu668@qq.com+86 18806815058

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026